RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arcadia Biosciences Inc (RKDA) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's poor financial performance, lack of positive trading trends, bearish technical indicators, and absence of strong catalysts make it an unattractive investment at this time.
The technical indicators for RKDA are bearish. The MACD is negative and expanding downward, RSI is neutral at 26.044, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 1.551 and S2 at 1.436, indicating further downside potential.
NULL identified. There are no significant positive news or trading trends to act as a catalyst for the stock.
The company reported a significant revenue decline of 26.2% YoY in Q4 2025, a net loss of $1.336 million, and a 67.45% YoY drop in EPS. Operating expenses remain high, and gross margin has dropped by 33.39% YoY. Additionally, there is no recent insider or hedge fund activity to suggest confidence in the stock.
Arcadia Biosciences reported poor financial performance in Q4 2025. Revenue dropped to $901,000 (-25.90% YoY), net income fell to -$1.336 million (-67.13% YoY), and EPS declined to -0.97 (-67.45% YoY). Gross margin also decreased significantly to 21.31% (-33.39% YoY).
No analyst rating or price target changes available for RKDA. Wall Street sentiment is neutral, with no significant pros or cons identified.
